Company / Inventory
ClearPoint Neuro, Inc. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$8.4M
FY2025
5-year range
$4.9M / $9.3M
FY2021-FY2025
Trend
+21.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory returned to growth in FY2025 after 2 years of decline, reaching $8M.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +20.9%.
Improved from $8M to $8M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -3.5%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +20.9%, indicating consistent growth.
- In FY2025, inventory increased 21.8% year-over-year.
- Peak inventory was recorded in FY2022.
- Lowest inventory in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.4M | +21.8% |
| FY2024 | $6.9M | -13.2% |
| FY2023 | $7.9M | -15.0% |
| FY2022 | $9.3M | +88.4% |
| FY2021 | $4.9M | +52.5% |
| FY2020 | $3.2M | -0.1% |
| FY2019 | $3.2M | +53.8% |
| FY2018 | $2.1M | -9.0% |
| FY2017 | $2.3M | +30.9% |
| FY2016 | $1.8M | -2.2% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026